Patent applications published 24 March 2010
- Therapeutic compounds
University of Florida Research Foundation 2164364*
- Oxyimino compounds and the use thereof
Shionogi & Co 2164325*
- Amide compounds and the use thereof
Euro-Celtique; Shionogi & Co 2164326*
- Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging
Washington University 2164327*
- Therapeutic pyrazoloquinoline urea derivatives
Helicon Therapeutics 2164328*
- Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
The Burnham Institute for Medical Research 2164329*
- SERCA2 therapeutic compsns and methods of use
Celladon 2164330*
- Boron-containing small molecules
Anacor Pharmaceuticals 2164331*
- Stable non-aqueous pharmaceutical compsns
Novo Nordisk 2164459*
- Pharmaceutical formulation for the production of rapidly disintegrating tablets
BASF 2164460*
- Pharmaceutical formulation for the production of chewable tablets and lozenges
BASF 2164461*
- Pharmaceutical formulation for the production of rapidly-disintegrating tablets
BASF 2164462*
- Concentrate esmolol
Baxter International 2164463*
- Multidose concentrate esmolol with benzyl alcohol
Baxter International 2164464*
- Self-emulsifying formulation of tipranavir for oral administration
Boehringer Ingelheim International 2164465*
- Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
Novo Nordisk 2164466*
- Slow release pharmaceutical compsn made of microparticles
Debio Recherche Pharmaceutique 2164467*
- Method for the production of a form of administration of a medicament
Grünenthal 2164468*
- Stable formulation of amorphous perindopril salts, a process for the preparation thereof on industrial scale and use thereof in the treatment of hypertension
Silverstone Pharma 2164469*
- Pharmaceutical compsn comprising desloratadine
Ratiopharm 2164470*
- Methods for improving physical function in fibromyalgia
Cypress Bioscience 2164471*
- Pharmaceutical compsn comprising a substrate and a coating containing an active ingredient and polyvinylalcohol
Schering-Plough Healthcare Products 2164472*
- An extended release compsn comprising a somatostatin derivative in microparticles
Novartis 2164473*
- Water dispersible polymer compsns
Dow Global Technologies 2164474*
- Therapeutic stable nanoparticles
Northeastern University 2164475*
- Topical compsn for treating pain
Xvasive 2164476*
- Pharmaceutical compsn having a trihydroxy-chromene derivative
Analyticon Discovery 2164477*
- PDZ domain modulators
University of Copenhagen; NeuroSearch 2164478*
- New sigma-receptor ligands with anti-apoptotic and/or pro-apoptotic properties over cellular biochemical mechanisms, with neuroprotective, anti-cancer, anti-metastatic and anti-(chronic) inflammatory action
Vamvakides, Alexandre 2164479*
- Mutual prodrugs and methods to treat cancer
University of Maryland 2164480*
- Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms
Bayer Consumer Care 2164481*
- Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
Galderma Research & Development 2164482*
- Transglutiminase inhibitor comprising chlorogenic acid and a method for producing thereof
National Cancer Center 2164483*
- Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension
Nicox 2164484*
- Combination of checkpoint kinase (CHK) and telaniectasia mutated (ATM) inhibitors for the treatment of cancer
AstraZeneca 2164485*
- Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compsns for treating or preventing pigment disorders
Galderma Research & Development 2164486*
- AMPA receptor antagonists and zonisamide for neuropathic pain
Eisai R&D Management 2164487*
- AMPA receptor antagonists and aldose reductase inhibitors for neuropathic pain
Eisai R&D Management 2164488*
- Combination of AMPA receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain
Eisai R&D Management 2164489*
- Pyrazoloyl derivatives with analgesic activity and therefore useful in the treatment of prophylaxis of pain
AstraZeneca 2164490*
- Piperidine-4-acetic acid derivatives and their uses
Euroscreen 2164491*
- (Thio)-carbamoyl-cyclohexane derivatives and method for treating schizophrenia
Richter Gedeon Nyrt 2164492*
- heteroaryl-substituted urea modulators of fatty acid amide hydrolase
Janssen Pharmaceutica 2164493*
- Methods of treatment
GlaxoSmithKline LLC 2164494*
- Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo-3,2-A pyrimidine or of 3-oxo-2,3-dihydro-5H-selenazolo--3,2-A pyrimidine or of 3-oxo-1,2,3-trihydro-5H-imidazolo-1,2-A pyrimidine for the preparation of pharmaceutical compsns intended for the treatment of cancer
Université Paris Descartes 2164495*
- A drug delivery system for the prevention of cerebral vasospasm
Macdonald, R; Leuthner, Brian 2164497*